We are Sorry, This Page doesn't Exist

Shares of Seattle Genetics Inc. gained 1.0% in trading on Friday after the Food and Drug Administration approved Tukysa for certain patients with HER2-positive breast cancer when given in combination with chemotherapy. The drug has a wholesale.....»»

Oil prices rose on Friday as President Donald Trump laid out plans to ease the U.S. coronavirus lockdown and on reports, later played down, that a drug may potentially help treat COVID-19......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

- New Drug Application for VP-102 for the treatment of molluscum contagiosum was accepted for filing by the U.S. Food and Drug Adm.....»»

Submitted New Drug Application (NDA) for LIQ861 in January 2020 Management to Host Webcast and Conference Call Today at 8:00 a.m. ET RESEARCH TRIANGLE P.....»»

New Drug Application (NDA) submission for tr.....»»

The jump comes amid a market slump on Monday. Gilead was one of two companies in the 100-stock Nasdaq Composite to post a gain as of mid-day Monday......»»

NDA (New Drug Application) and Marketing Authorization Application (MAA) completed in February 2020Commercial readiness activities in U.S. underway for potential launch of PEDMARKTM, if approved, in the second half of 2020Solid financial p.....»»

Bausch Health Cos. iNc. said Wednesday it is reducing debt by $100 million using cash from operations. The drug company, formerly called Valeant, h.....»»

FibroGen Inc. will receive $50 million from partner AstraZeneca after federal regulators accepted the San Francisco company's application to approve a drug for treating anemia in chronic kidney disease patients. Acceptance of FibroGen's new drug appl.....»»

Shares of Allergan PLC rose 1% in premarket trading Monday, after the drug maker reported a fourth-quarter adjusted profit and revenue.....»»

Vivus shares jumped on Wednesday after the company announced a crucial FDA for its supplemental New Drug Application for an improved formulation of Pancreaze......»»

Shares of McKesson Corp. were up 0.69% in premarket trading on Tuesday after the drug distributor said its adjusted earnings beat expectations for the quarter. Earnings tumbled to $191 million, or $1.03 per share, in the third quarter of 202.....»»

GW Pharmaceuticals PLC said Monday it has submitted a supplemental New Drug Application (NDA) to expand the label for Epidiolex cannabidiol oral solution, .....»»

The gain comes from a drop in cancer deaths and fatal drug overdoses in 2018.....»»

Vertex Pharmaceuticals Inc. shares rose in the extended session Thursday after the biotech drug maker's results and forecast topped Wall Street estimates. Vertex shares rose 2.9% after .....»»

The gain comes from a drop in cancer deaths and fatal drug overdoses in 2018.....»»

Shares of Johnson & Johnson slipped 0.1% in premarket trading Wednesday, after the consumer products and drug giant reported a fourth-quarter profit that beat expectations but revenue that came up a bit shy. Net income rose to $4.01 billion, o.....»»

Shares of Tyme Technologies were up 23% in premarket trading on Tuesday after the biotechnology company said it had formed a c.....»»

Mesoblast Limited (Nasdaq: MESO) announced that the United States Food and Drug Administration (US FDA) has confirmed receipt of Mesoblast's .....»»